Q&A: MPI's Hans Lehrach on Combining Deep Sequencing and Predictive Models to Improve Cancer Therapy

Hans Lehrach heads the Department of Vertebrate Genomics at the Max Planck Institute for Molecular Genetics in Berlin and is involved in many projects — including the 1000 Genomes Project — that make use of the institute's 14 second-generation sequencing instruments.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.